Welcome to our dedicated page for Fortive news (Ticker: FTV), a resource for investors and traders seeking the latest updates and insights on Fortive stock.
Fortive Corporation reports developments across a diversified industrial technology business focused on essential products, software, and services. Its continuing operations are organized around Intelligent Operating Solutions and Advanced Healthcare Solutions, with brands and platforms tied to maintenance, repair, measurement, condition monitoring, worker safety, compliance, facilities, and healthcare technology markets.
Recurring Fortive news includes quarterly results, earnings calls, share repurchase authorizations, investor conference appearances, and updates following the completed separation of its former Precision Technologies segment into Ralliant. Product news often centers on Fluke offerings such as RotAlign laser shaft alignment systems, SmartTrace underground utility locators, and eMaint CMMS/EAM software with artificial intelligence features for maintenance work.
Fluke (NYSE:FTV) launched a beta of a purpose-built AI upgrade to eMaint CMMS/EAM on March 16, 2026, adding voice-driven work-order creation, searchable AI answers from maintenance data, and an SOP Builder that can cut preventive maintenance creation time by 50%+.
The beta is available now to select customers, with broader rollout planned after refinement; features aim to speed decision-making, improve safety, and capture retiring technicians' knowledge.
Fluke (NYSE:FTV) partnered with Washington State University on March 6, 2026 to donate professional test-and-measurement tools, create the Fluke Engineering Lab at WSU Everett, and standardize Fluke equipment across five WSU campuses.
More than 4,000 Voiland College students will access over 30 professional Fluke tools integrated into upper-level courses and library checkout, plus expanded mentorship connections to industry professionals.
Fortive (NYSE: FTV) will present at the 2026 J.P. Morgan Industrials Conference on Tuesday, March 17, 2026 at 12:20 p.m. ET. Mark Okerstrom, Chief Financial Officer, will deliver the presentation. The audio will be webcast and archived on Fortive’s Investors website for replay.
Fortive (NYSE: FTV) declared a regular quarterly cash dividend of $0.06 per share, payable March 27, 2026 to shareholders of record on March 13, 2026.
The Board noted dividends are expected quarterly but future payments, amounts, record dates and payment dates remain at the Board's discretion.
Fortive (NYSE: FTV) reported Q4 2025 revenue of $1.12B (+4.6% reported, core +3.3%) and FY 2025 revenue of $4.16B (+1.9% reported, core +1.7%).
FY GAAP diluted EPS was $1.59 (+16.1%); adjusted diluted EPS was $2.71 (+12%). Fortive deployed $1.6B in share repurchases in 2025 and initiated 2026 adjusted EPS guidance of $2.90–$3.00.
Fortive (NYSE: FTV) said CEO Olumide Soroye and CFO Mark Okerstrom will present at two investor conferences in February 2026: Citi's Global Industrial Tech and Mobility Conference on Feb 17, 2026 at 3:30 p.m. ET and Barclays' 43rd Annual Industrial Select Conference on Feb 18, 2026 at 11:35 a.m. ET.
According to the company, the audio will be webcast live and archived in the Investors section of Fortive’s website.
Fluke Networks (NYSE:FTV) launched CertiFiber Max, a third-generation optical loss test set for high-density data centres that delivers native MMC and MPO support and certifies up to 24 fibres in under one second. Built on the Versiv platform and integrated with LinkWare, it uses field-replaceable UniPort adapters supporting 12/16/24 MPO and 16/24 MMC (pinned and unpinned) to reduce fan-out complexity and extend tester lifecycle. The tester measures loss, length, and polarity using the one-jumper reference method to improve speed and accuracy for AI and cloud data-centre deployments.
Advanced Sterilization Products (FTV) announced on Jan 15, 2026 that the ULTRA GI™ Cycle for the STERRAD™ 100NX Sterilizer with ALLClear™ Technology received CE mark approval in partnership with FUJIFILM Healthcare Europe. The cycle adds hydrogen peroxide gas plasma sterilization for duodenoscopes, including compatibility for FUJIFILM models ED-840T and ED-840XT. Existing STERRAD 100NX customers can obtain the ULTRA GI Cycle via a cycle upgrade on installed equipment, while ASP will work with device makers to design future duodenoscopes for hydrogen peroxide compatibility. The move aims to strengthen reprocessing confidence and patient safety across European healthcare settings.
ASP (NYSE: FTV) announced that the ULTRA GI™ Cycle for the STERRAD™ 100NX Sterilizer with ALLClear Technology has received CE mark approval, enabling validated hydrogen peroxide gas plasma sterilization for complex duodenoscopes across Europe. The ULTRA GI Cycle adds compatibility for FUJIFILM duodenoscope models ED-840T and ED-840XT, and current customers with a STERRAD 100NX with ALLClear can obtain the new cycle via a cycle upgrade on existing equipment. ASP said it will work with device manufacturers to promote broader hydrogen peroxide compatibility for future duodenoscope models, positioning the technology as a tool to improve reprocessing and patient safety.
Fortive (NYSE: FTV) will webcast its fourth quarter 2025 earnings conference call on Wednesday, February 4, 2026 at 12:00 p.m. ET. The call is expected to last approximately one hour and will include an accompanying presentation. Investors can access the live webcast and a digital replay via the Investors section of Fortive's website under News & Events, and materials will be posted under Financial Info. Dial-in numbers for the call are 877-407-3110 (U.S.) and +1 215-268-9915 (outside the U.S.).